Acadesine, an adenosine-regulating agent with the potential for widespread indications

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 12, 2008, Pages 2137-2144

  Drew, Brian G ^a   Kingwell, Bronwyn A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Acadesine; Adenosine; AICAR; AMP kinase

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE TRIPHOSPHATE; CHLORAMBUCIL; PLACEBO; PURINE; PURINE ANTAGONIST; STEROID;

ABSENCE OF SIDE EFFECTS; APOPTOSIS; B CELL LEUKEMIA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; ENERGY METABOLISM; GLUCOSE METABOLISM; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MONOTHERAPY; NONHUMAN; REPERFUSION INJURY; REVIEW; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; SYSTEMIC THERAPY; VITAL SIGN;

ADENOSINE; AMINOIMIDAZOLE CARBOXAMIDE; CORONARY ARTERY BYPASS; DIABETES MELLITUS; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MYOCARDIAL REPERFUSION INJURY; RIBONUCLEOSIDES;

EID: 50949114804     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.12.2137     Document Type: Review

References (45)

1. Mangano DT. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA 1997;277:325-32
2. Mangano DT, Miao Y, Tudor IC, Dietzel C. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. J Am Coll Cardiol 2006;48:206-14
3. Campas C, Lopez JM, Santidrian AF, et al. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 2003;101:3674-80
4. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997;273:E1107-12
5. Cuthbertson DJ, Babraj JA, Mustard KJ, et al. AICAR acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes 2007;56(8):2078-84
6. Gruber HE, Hoffer ME, McAllister DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Eflects on flow, granulocytes, and injury. Circulation 1989;80:1400-11
7. Vincent MF, Marangos PJ, Gruber HE, Van den Berghe G. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 1991;40:1259-66
8. Zhang L, Frederich M, He H, Balschi JA. Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart. Am J Physiol Heart Circ Physiol 2006;290:H1235-43
9. Young MA, Henry C, Wong S, et al. Acadesine reduces the frequency of coronary artery reocclusion following rt-PA induced thrombolysis in the dog. Thromb Haemost 1995;74:1348-52
10. Bullough DA, Zhang C, Montag A, et al. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. J Clin Invest 1994;94:1524-32
11. Hardie DG, Salt IP, Hawley SA, Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 1999;338(Pt 3):717-22
12. Vavvas D, Apazidis A, Saha AK, et al. Contraction-induced changes in acetyl-CoA carboxylase and 5-AMP-activated kinase in skeletal muscle. J Biol Chem 1997;272:13255-61
13. Sakoda H, Ogihara T, Anai M, et al. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab 2002;282:E1239-44
14. Velasco G, Geelen MJ, Guzman M. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 1997;337:169-75
15. Sullivan JE, Carey F, Carling D, Beri RK. Characterisation of 5′-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5′-AMP analogues on enzyme activity. Biochem Biophys Res Commun 1994;200:1551-56
16. Bergeron R, Russell RR 3rd, Young LH, et al. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol 1999;276:E938-44
17. Dagher Z, Ruderman N, Tornheim K, Ido Y. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999;265:112-5
18. Guigas B, Taleux N, Foretz M, et al. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J 2007;404:499-507
19. Jacobs RL, Lingrell S, Dyck JR, Vance DE. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-bera-4-ribofuranoside is independent of AMP-activated protein kinase activation. J Biol Chem 2007;282:4516-23
20. Meley D, Bauvy C, Houben-Weerts JH, et al. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006;281:34870-9
21. Hoffmeister HM, Mauser M, Schaper W. Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium. Basic Res Cardiol 1985;80:445-58
22. Mauser M, Hoffmeister HM, Nienaber C, Schaper W. Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog. Circ Res 1985;56:220-30
23. Foley JM, Adams GR, Meyer RA. Utility of AICAr for metabolic studies is diminished by systemic effects in situ. Am J Physiol 1989;257:C488-94
24. Young MA, Mullane EM. Progressive cardiac dysfunction with repeated pacing-induced ischemia: protection by AICA-riboside. Am J Physiol 1991;261:H1570-7
25. Dixon R, Gourzis J, McDermott D, et al. AICA-riboside: safety, tolerance, and pharmacokinetics of a novel adenosine-regulating agent. J Clin Pharmacol 1991;31:342-7
26. Dixon R, Fujitaki J, Sandoval T, et al. (AICA-riboside): disposition and metabolism of an adenosine-regulating agent. J Clin Pharmacol 1993;33:955-8
27. Cotton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995;229:558-65
28. Koistinen HA, Galuska D, Chibalin AV, et al. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 2003;52:1066-72
29. Ross AM, Gibbons RJ, Stone GW, et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005;45:1775-80
30. Longnus SL, Wambolt RB, Parsons HL, et al. 5-Aminoimidazote-4-carboxamide 1-beta-D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. Am J Physiol Regul Integr Comp Physiol 2003;284:R936-44
31. Gadalla AE, Pearson T, Currie AJ, et al. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. J Neurochem 2004;88:1272-82
32. Leung JM, Stanley T 3rd, Mathew J, et al. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group. Anesth Analg 1994;78:420-34
33. Marzille M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000;101:2154-9
34. Mahaffey KW, Puma JA. Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999;34:1711-20
35. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-146
36. Allender S, Scarborough P, Peto V, Rayner M. British Heart Foundation Health Promotion Research European Cardiovascular Disease Statistics; 2008. Available from: http://www.heartstats.org/datapage.asp?id=7683
37. Davies J, Senes S. Cardiac surgery in Australia 1999. Australian Institute of Health and Welfare National Heart Foundation of Australia, 2003. Available from: http://152.91.62.50/publications/cvd/csa99/ csa99.pdf
38. Nagle PC, Smith AW. Review of recent US cost estimates of revascularization. Am J Manag Care 2004;10:S370-6
39. Keating MJ, Kantarjian H, Talpaz M, et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989;74:19-25
40. Steurer M, Pall G, Richards S, et al. Purine antagonists for chronic lymphocytic leukaemia. Cochrane Database Syst Rev 2006;3:CD004270
41. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22; discussion 822-3
42. Alfayoumi F, Srinivasan V, Geller M, Gradman A. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach. Rev Cardiovasc Med 2005;6:72-83
43. Hawley SA, Gadalla AE, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 2002;51:2420-5
44. Shaw RJ, Lamia KA, Vasquez D, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005;310:1642-6
45. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-74